Researchers at McMaster University have developed a new cancer immunotherapy strategy that can simultaneously attack deadly brain tumors and the immune cells that help them grow.

The following is a summary of a story by Adriana Difranco on MADE FOR THIS. Chemotherapy drugs for brain tumors typically haven’t been able to get past the blood-brain barrier, says Duke neurosurgeon ...

The company said on Friday night that the federal government had ordered limits on its Mythos and Fable 5 A.I. systems, citing national security concerns. By Cade Metz and Dustin Volz Cade Metz ...

Professor Richard Scolyer, renowned pathologist and joint Australian of the Year (2024), has died at the age of 59. Scolyer captured the attention of Australians and the world when he volunteered to ...

June 3 (Reuters) - Today we revisit the American Society of Clinical Oncology scientific meeting in Chicago, which concluded on Tuesday, to report on three more potentially practice-changing studies.

Brain tumors are one of the most devastating consequences of cancer’s spread—hard to treat and highly deadly. Scientists have found that using a radioactive implant precisely where a tumor was removed ...

High-precision liver and tumor segmentation is a cornerstone of digital oncology, yet its clinical deployment remains constrained by two persistent challenges: the scarcity of pixel-level annotations ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We celebrated my twin son and daughter’s seventh birthday on November ...

New research from Peter Mac has uncovered why some parts of the brain may be more vulnerable to tumor growth than others, offering new clues into how brain cancers begin and how they could one day be ...

The deported mother of a U.S. citizen child who was recovering from a rare brain tumor recently found out she was denied a humanitarian request to return to the United States to continue her ...